Rubicon Research
Mainboard₹14,550 / 30 Shares
IPO Live Subscription Details
| Category | Subscription (Times) |
|---|---|
| Date | 13 Oct 2025, 06:57 PM |
| QIBs | 137.09 times |
| NII | 102.71 times |
| Retail | 37.33 times |
| Employee | 17.69 times |
| Total | 109.33 times |
Rubicon Research IPO Details
The Rubicon Research IPO price band is set between ₹461-485 per equity share, with a face value of ₹1 per share. The issue is managed by Axis Capital LtdIIFL Capital Services LtdJM Financial LtdSBI Capital Markets Ltd, and the equity shares are proposed to be listed on the Mainboard.
The IPO date for subscription opens on 9 Oct, 2025 and closes on 13 Oct, 2025. Investors can check the allotment status on 14 Oct, 2025, while the listing date is tentatively scheduled for 16 Oct, 2025.
The total issue size is 2,84,02,040 shares, aggregating up to ₹1377.5 crore. Stay tuned for the latest Rubicon Research IPO review and GMP updates.
Rubicon Research IPO Review, Rating & Analysis
Rubicon Research IPO Review
NO REVIEWRubicon Research IPO Rating
Rubicon Research IPO Highlights
IPO Date
Oct 9, 2025 - Oct 13, 2025
Listing Date
16 Oct, 2025
Face Value
₹1 Per Equity Share
Price Band
₹461-485 per equity share
Lot Size
30 Shares
Fresh Issue
Shares
Offer for Sale
-
Listing At
BSE, NSE
Rubicon Research IPO Lot Size
The minimum market lot for Rubicon Research IPO is 30 shares with an application amount of ₹14,550. Retail investors can apply for up to 13 lots. The table below details the minimum and maximum investment limits for Retail and HNI investors.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 30 | ₹14,550 |
| Retail (Max) | 13 | 390 | ₹1,89,150 |
| S-HNI (Min) | 14 | 420 | ₹2,03,700 |
| S-HNI (Max) | 68 | 2040 | ₹9,89,400 |
| B-HNI (Min) | 69 | 2070 | ₹10,03,950 |
Rubicon Research IPO Timeline
Issue Price
₹461-485 per equity shareFace Value
₹1 Per Equity ShareListing at Group
BSE, NSERegistrar
Axis Capital LtdIIFL Capital Services LtdJM Financial LtdSBI Capital Markets LtdLead Manager
MUFG Intime India Pvt.Ltd.Issue Size
2,84,02,040 shares(aggregating up to ₹1377.5 crore)Rubicon Research IPO Valuations
EPS Pre IPO
₹8.70/-EPS Post IPO
₹10.51/-PE Pre IPO
55.75PE Post IPO
46.13ROE
29.02%ROCE
26.45%Debt Equity
0.73RoNW
29.02%PAT Margin
10.37%Price to Book Value
-Promoters & Share Holding
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| N/A | N/A |
About Company
Founded in 1999, Rubicon Research Limited is a pharmaceutical organization that deals with the development, manufacturing, and marketing of differentiated formulation.
As of March 31, 2024, Rubicon Research Limited had an approved portfolio of 69 active Abbreviated New Drug Application (ANDA) and New Drug Application (NDA) products of the US FDA. The portfolio comprises 55 commercialized products of which the US generic pharmaceutical market size is USD 2,386.6 million and which has contributed USD 154.3 million by Rubicon Research Limited during Fiscal 2024.
Rubicon Research IPO Subscription Details
| As on | QIB | NII bNII sNII | Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 85,06,804 | 42,54,299 28,36,200 14,18,100 | 28,36,200 | 1,56,37,349 |
Day 109-10-25 05:00 PM | 0.27 x | 0.49 0.40 x 0.68 x | 1.47 x | 0.55 x |
Day 210-10-25 05:00 PM | 2.22 x | 1.93 1.60 x 2.58 x | 4.19 x | 2.50 x |
Day 313-10-25 05:00 PM | 137.09 x | 102.70 117.77 x 72.57 x | 37.33 x | 109.33 x |
Retail:29.41x
BHNI:23.02x
SHNI:69.28x
Rubicon Research IPO - Issue Objectives & Utilisation of proceeds
| Objectives | Amount |
|---|---|
| Prepayment or scheduled repayment of all or a portion of certain outstanding borrowings availed by the Company | - |
| Funding inorganic growth through unidentified acquisitions and other strategic initiatives and General corporate purposes | - |
Company Contact Details
Rubicon Research
MedOne House, B-75, Road No. 33, Wagle Estate, Thane West-400604, Maharashtra, India Thane, Maharashtra, 400604Registrar Contact Details
MUFG Intime India Private Limited (Link Intime)
Phone: +91-22-4918 6270
Email: rubicon.ipo@linkintime.co.in
Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html
Frequently Asked Questions about Rubicon Research IPO
When will Rubicon Research IPO open for subscription?
The Rubicon Research IPO opens on 9 Oct, 2025 and closes on 13 Oct, 2025.
What is the investors portion for Rubicon Research IPO?
The investors' portion for QIB is 137.09 x, NII is 117.77 x, and Retail is 37.33 x.
How to apply for Rubicon Research IPO?
You can apply for Rubicon Research IPO via ASBA online through your bank account. You can also apply via UPI through stock brokers like Zerodha, Upstox, or Paytm Money.
What is the issue size of Rubicon Research IPO?
The issue size of Rubicon Research IPO is approx ₹2,84,02,040 shares(aggregating up to ₹1377.5 crore) crores.
What is the price band of Rubicon Research IPO?
The price band for Rubicon Research IPO is ₹461 to ₹485 per equity share.
What is the lot size of Rubicon Research IPO?
The minimum bid (lot size) for Rubicon Research IPO is N/A shares with an investment of approx ₹14,550 .
What is the allotment date of Rubicon Research IPO?
The allotment date for Rubicon Research IPO is 14 Oct, 2025.
What is the listing date of Rubicon Research IPO?
The listing date for Rubicon Research IPO is expected to be 16 Oct, 2025.
What is the GMP of Rubicon Research IPO?
The latest Grey Market Premium (GMP) for Rubicon Research IPO is being updated regularly on IPOROCK.
Parth D.
Founder & Lead Analyst
Parth D. is a software engineer and financial analyst who brings a quantitative edge to IPO tracking. With deep expertise in algorithmic trading and financial tool development, he builds the technology that powers IPORock's real-time data engines. He has been tracking the Indian market since 2018.